Axiomedix, Inc.

What Axiomedix, Inc. does

Axiomedix operates the Connect+ Health Data Ecosystem, a two-sided B2B marketplace that connects healthcare organizations (hospitals, clinics, research institutions) sharing anonymized health data with researchers, pharmaceutical and biotech firms, government agencies, and patient advocacy groups seeking diverse datasets for studies. The platform supports both low-resolution data (EHR, claims, admissions) and high-resolution data (omics, imaging, streaming, translational), protected by a Secure Enclave environment with advanced encryption and the 5 Safes Data Governance Framework (Safe People, Safe Projects, Safe Settings, Safe Data, Safe Outputs), with stated HIPAA and GDPR compliance. Marketplace mechanics enable data exchange at local, regional, national, and global scopes depending on supplier preference.

The company's revenue model rests on marketplace commissions on data transactions and data monetization services for healthcare organizations seeking new revenue streams from their data assets. Pricing is quote-based with no public tiers, and the GTM combines an enterprise field-sales motion (targeting researchers, data scientists, healthcare professionals, pharma, biotech, and government) with content-led website marketing organized around five customer-segment resource pages. Operating presence is established in the US (Bedford, MA HQ), UK, and Canada.

Axiomedix was founded by Keith Elliston, who previously co-founded the tranSMART Foundation in 2013 and orchestrated the 2016 merger forming the i2b2-tranSMART Foundation, giving the company inherited credibility in the translational research community. Management includes a CFO (Steve Johnson) with public/private company finance experience, a CTO (Scott Blodgett) with Optum Analytics and health-system backgrounds, and a Director of Data Science and AI (M. Kendra Elliston). The firm has raised a single disclosed $200K seed round from Seneca Creek Ventures in 2018 and operates with 11-50 employees.

Name

Axiomedix, Inc.

Legal name

Axiomedix, Inc.

Website

https://axiomedix.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Axiomedix operates Connect+, a secure B2B healthcare data marketplace enabling anonymized data exchange between healthcare organizations and researchers, pharma, biotech, government, and advocacy groups. The platform supports diverse EHR, claims, omics, and imaging datasets under HIPAA/GDPR-compliant Secure Enclave and 5 Safes governance.

Ownership category

akta.pro rank

Product category

Health Data Marketplace

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)

akta.pro secondary industries

De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK), Healthcare Data Integration, ETL/ELT & Pipeline Orchestration (HLACAIAC)

Keywords

• Health data marketplace
• Healthcare data exchange
• Clinical research data
• Anonymized health data
• Data monetization platform

Headquarters

HQ city

Bedford

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Health Data Marketplace Commission: Axiomedix operates a marketplace platform connecting healthcare data suppliers with data consumers. Healthcare organizations share anonymized data on the platform, and researchers/companies access datasets for studies and drug development. The platform likely generates revenue through transaction fees or subscription access to data.
2. Data Monetization Services for Healthcare Organizations: Healthcare organizations can unlock value from their data while maintaining security and compliance. The platform enables data suppliers to reach audiences at multiple levels (local, regional, national, global) providing new revenue streams for organizations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Axiomedix operates the Connect+ Health Data Ecosystem, a B2B marketplace platform that connects healthcare organizations (hospitals, clinics, health systems) sharing anonymized health data with researchers, pharmaceutical companies, biotech firms, and government agencies seeking diverse datasets for studies and drug development. The platform supports both low and high resolution data types including EHR, claims, admissions, omics, imaging, streaming, and translational data, and uses secure enclave technology, advanced encryption, and the 5 Safes Governance Framework to ensure HIPAA and GDPR compliance.

Product overview

Axiomedix operates a unified platform called the Connect+ Health Data Ecosystem, which consists of the Connect+ Marketplace as the core data exchange layer, the Secure Enclave module for privacy-protected analytics, and the 5 Safes Data Governance Framework for compliant data management. Together, these components enable healthcare organizations to share anonymized data while providing researchers access to diverse datasets.

Differentiator

Problem solved

Functional benefit

Brands

• Connect+ Health Data Ecosystem: A secure marketplace platform connecting healthcare organizations that share anonymized data with researchers seeking diverse datasets for studies. Uses secure enclaves and advanced encryption techniques.

Products and services

• Connect+ Health Data Ecosystem A secure marketplace platform that connects healthcare organizations sharing anonymized data with researchers and industry partners seeking diverse datasets for studies, drug development, and innovation. The ecosystem champions inclusivity, equity, and data diversity, and operates at local, regional, national, and global levels.

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• HealthVerity: HealthVerity runs a healthcare data marketplace that links, de-identifies, and licenses longitudinal patient data from a broad supplier network to pharma, biotech, and government consumers. It directly competes with Axiomedix in enabling secure, compliant exchange of clinical and real-world data for research.
• Datavant: Datavant operates a healthcare data connectivity and de-identification platform linking patient-level data across providers, payers, and life sciences. It is the most directly comparable two-sided health data marketplace to Axiomedix's Connect+ offering, with both focused on enabling privacy-preserving data exchange between healthcare data holders and research consumers.
• Tempus AI: Tempus AI operates a precision medicine data platform aggregating clinical and molecular (omics) data from health systems for use by providers, researchers, and pharma. It overlaps with Axiomedix on the multi-modality data (omics + clinical) marketplace concept and serves similar life sciences data consumers.

Broad incumbents

• IQVIA: IQVIA combines clinical research services, real-world evidence, and healthcare data at massive scale for life sciences customers. While much broader than Axiomedix, its data licensing and analytics arms overlap directly with the demand-side use cases Axiomedix targets.
• Medidata Solutions: Medidata (Dassault Systèmes) provides clinical trial data capture and analytics used by pharma and biotech sponsors globally. Its clinical trial data platform overlaps with Axiomedix's translational research use cases and represents the kind of incumbent data infrastructure Axiomedix aims to complement or compete with for research customers.
• Flatiron Health: Flatiron Health (acquired by Roche) aggregates oncology EHR and real-world data from community practices and links them to research and life sciences consumers. It is a broad incumbent in oncology-focused health data marketplaces and a relevant comparator for Axiomedix's claims of diverse data supply and pharma/biotech consumption.
• Snowflake: Snowflake provides cloud data platform infrastructure used by health systems, payers, and life sciences organizations for secure data sharing and analytics, including healthcare-specific data clean rooms. It is a broad incumbent whose Healthcare & Life Sciences data sharing capabilities overlap with Axiomedix's secure enclave and marketplace concepts.

Emerging players

• Owkin: Owkin operates a federated learning and AI platform enabling researchers to train models on decentralized healthcare data without moving it, with a strong emphasis on multi-modal and diverse datasets. It is comparable to Axiomedix's privacy-preserving, diversity-focused data exchange positioning for life sciences research.
• PHEMI Systems: PHEMI Systems built a healthcare data governance and sharing platform with privacy controls and de-identification tools for hospitals and researchers. Axiomedix's CTO Scott Blodgett previously served as CTO at PHEMI, indicating close lineage; the platforms share architectural roots in governed, privacy-preserving health data exchange.
• Curoverse: Curoverse built open-source genomic and biomedical data management tools for clinical and translational use. Axiomedix CEO Keith Elliston previously served as Chief Commercial Officer at Curoverse, indicating direct technological and conceptual lineage to Axiomedix's open-data-sharing approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/AxiomedixInc
• LinkedInlinkedin.com/company/axiomedix

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axiomedix, Inc.